Bioventus (BVS) Gross Profit Growth (3y) (2023 - 2026)
Bioventus (BVS) Gross Profit Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.85 Bn | 176.55 Bn | 6.27 Bn | 5.02% |
| 2 | Stryker | 128.90 Bn | 126.02 Bn | 3.81 Bn | 8.10% |
| 3 | Medtronic | 108.55 Bn | 99.33 Bn | 6.41 Bn | 4.81% |
| 4 | Boston Scientific | 68.56 Bn | 67.10 Bn | 3.61 Bn | 15.44% |
| 5 | Edwards Lifesciences | 48.24 Bn | 44.57 Bn | 1.29 Bn | 9.03% |
| 6 | Dexcom | 28.40 Bn | 27.28 Bn | 750.30 Mn | 17.49% |
| 7 | GE HealthCare Technologies | 28.15 Bn | 25.87 Bn | 1.98 Bn | 1.49% |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | - |
| 9 | Koninklijke Philips | 24.75 Bn | 21.63 Bn | 2.07 Bn | 3.15% |
| 10 | Bioventus | 826.39 Mn | 790.55 Mn | 90.77 Mn | 7.08% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 7.08% |
| Dec 31, 2025 | 13.61% |
| Sep 27, 2025 | 3.69% |
| Jun 28, 2025 | 1.84% |
| Mar 29, 2025 | 3.14% |
| Dec 31, 2024 | 5.36% |
| Sep 28, 2024 | 5.77% |
| Jun 29, 2024 | 10.74% |
| Mar 30, 2024 | 14.06% |
| Dec 31, 2023 | 5.51% |
| Sep 30, 2023 | 8.07% |
| Jul 1, 2023 | 30.23% |
| Apr 1, 2023 | 8.90% |